Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
therapeutics tags : Pre-clinical save search
Akari Therapeutics to Present PAS-Nomacopan Pre-Clinical Electroretinography (ERG) Data at ARVO 2024
Published: 2024-04-15 (Crawled : 12:00) - globenewswire.com
AKTX | $1.11 -8.26% -9.01% 3.7K
|
Health Technology
|
| O: -3.15%
H: 3.24%
C: -2.44%
pre-clinical therapeutics
Hoth Therapeutics Announces Positive Data In Completed Study of Alzheimer's Disease Pre-Clinical Treatment with HT-ALZ
Published: 2024-03-19 (Crawled : 15:30) - biospace.com/
HOTH | $1.22 3.39% 3.28% 22K
|
Health Technology
|
| O: 21.74%
H: 19.29%
C: -3.57%
disease pre-clinical positive treatment alzheimer's therapeutics ht-alz study
TransCode Therapeutics Reports Positive Pre-Clinical Results in Metastatic Pancreatic Cancer with its Lead Candidate, TTX-MC138TTX-MC138 is Effective in Animal Models of Human Metastatic Pancreatic Cancer
Published: 2023-12-12 (Crawled : 14:00) - biospace.com/
RNAZ | $0.49 -2.39% -2.45% 110K
|
Professional, Scientific, and T...
|
| O: 11.94%
H: 0.0%
C: -19.05%
mc138 pre-clinical animal positive cancer pancreatic therapeutics results
TransCode Therapeutics Reports Positive Pre-Clinical Results in Metastatic Pancreatic Cancer with its Lead Candidate, TTX-MC138
Published: 2023-12-12 (Crawled : 13:30) - globenewswire.com
RNAZ | $0.49 -2.39% -2.45% 110K
|
Professional, Scientific, and T...
|
| O: 11.94%
H: 0.0%
C: -19.05%
mc138 ttx-mc138 pre-clinical positive cancer pancreatic therapeutics results
Akari Therapeutics Presents Poster on Progress in Pre-Clinical Development of Long-Acting PAS-Nomacopan as a Potential Treatment for Geographic Atrophy at the 4th Annual Dry AMD Therapeutic Development Conference
Published: 2023-11-16 (Crawled : 13:00) - globenewswire.com
AKTX | $1.11 -8.26% -9.01% 3.7K
|
Health Technology
|
| O: 9.78%
H: 0.0%
C: -7.18%
conference pre-clinical treatment therapeutics potential
Akari Therapeutics to Present a Poster on Pre-Clinical Development of Long-Acting PAS-Nomacopan as a Potential Treatment for Geographic Atrophy at the 4th Annual Dry AMD Therapeutic Development Conference
Published: 2023-11-06 (Crawled : 13:00) - globenewswire.com
AKTX | $1.11 -8.26% -9.01% 3.7K
|
Health Technology
|
| O: -0.28%
H: 2.36%
C: 2.36%
conference pre-clinical treatment therapeutics potential
Sangamo Therapeutics to Present Pre-Clinical Data Showcasing Its Epigenetic Regulation for Neurology and CAR-Treg Research at the 30th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)
Published: 2023-10-24 (Crawled : 10:00) - biospace.com/
SGMO | $0.5143 6.02% 5.68% 1M
|
Health Technology
|
| O: 1.79%
H: 6.51%
C: -1.9%
pre-clinical congress cell research therapeutics therapy
Aprea Unveils Initial Clinical Data on ATRi, ATRN-119, and Pre-Clinical Data on WEE1i, ATRN-1051, at AACR-NCI-EORTC International Conference Supporting Highly Differentiated Synthetic Lethality Portfolio
Published: 2023-10-16 (Crawled : 12:30) - globenewswire.com
APRE | $5.65 0.71% 0.71% 7.2K
|
Health Technology
|
| O: 4.37%
H: 0.55%
C: -5.28%
atrn-119 conference pre-clinical international
Foghorn Therapeutics to Present Clinical and Pre-Clinical Data from Multiple Programs Across Its Diverse Pipeline at AACR-NCI-EORTC International Conference
Published: 2023-10-04 (Crawled : 12:00) - globenewswire.com
FHTX | $5.335 -3.53% -3.66% 120K
|
Health Technology
|
| O: -0.24%
H: 1.07%
C: -4.28%
conference pre-clinical international pipeline therapeutics
TransCode Therapeutics Announces Positive Pre-Clinical Glioblastoma Results with Lead Therapeutic Candidate, TTX-MC138Further Supports TTX-MC138 Application in Brain Cancer
Published: 2023-09-25 (Crawled : 17:00) - biospace.com/
RNAZ | $0.49 -2.39% -2.45% 110K
|
Professional, Scientific, and T...
|
| O: 97.29%
H: 144.27%
C: 94.66%
mc138 ttx-mc138 pre-clinical positive cancer application therapeutics results glioblastoma
TransCode Therapeutics Announces Positive Pre-Clinical Glioblastoma Results with Lead Therapeutic Candidate, TTX-MC138
Published: 2023-09-25 (Crawled : 13:00) - globenewswire.com
RNAZ | $0.49 -2.39% -2.45% 110K
|
Professional, Scientific, and T...
|
| O: 97.29%
H: 144.27%
C: 94.66%
mc138 ttx-mc138 pre-clinical positive therapeutics results glioblastoma
Corbus Pharmaceuticals to Present Pre-Clinical Data Characterizing its CRB-701 Nectin-4 ADC at the at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Published: 2023-09-19 (Crawled : 14:00) - biospace.com/
CRBP | $39.12 7.09% 6.62% 280K
|
Health Technology
|
| O: 0.0%
H: 1.29%
C: -2.68%
crb-701 conference pre-clinical cancer international pharmaceuticals therapeutics molecular
Shuttle Pharma's Selective HDAC6 Inhibitor Shown to Stimulate Innate Immune Response in Pre-clinical Studies, as Reported in Molecular Cancer Therapeutics
Published: 2023-08-29 (Crawled : 13:30) - biospace.com/
SHPH | $0.409 1.89% 1.86% 12K
|
|
| O: 3.76%
H: 4.71%
C: 1.96%
pre-clinical cancer therapeutics response molecular
Marker Therapeutics Reports Pre-Clinical Data of its MT-601 MultiTAA-Specific T Cell Product Candidate in Lymphoma CellsMT-601 showed anti-tumor activity against CD19 CAR T refractory lymphoma cells in vitro
Published: 2023-05-31 (Crawled : 11:00) - biospace.com/
MRKR | $4.25 3.65% 3.52% 15K
|
Consumer Services
|
| O: 39.11%
H: 5.41%
C: -3.78%
mt-601 candidate pre-clinical cell cd19 therapeutics in vitro
Marker Therapeutics Reports Pre-Clinical Data of its MT-601 MultiTAA-Specific T Cell Product Candidate in Lymphoma Cells
Published: 2023-05-31 (Crawled : 11:00) - globenewswire.com
MRKR | $4.25 3.65% 3.52% 15K
|
Consumer Services
|
| O: 39.11%
H: 5.41%
C: -3.78%
mt-601 candidate pre-clinical cell therapeutics
Protagonist Reports Positive Results from Phase 1 and Pre-clinical Studies of Oral Interleukin-23 Receptor Antagonist JNJ-2113
Published: 2023-05-12 (Crawled : 11:00) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.23%
H: 0.12%
C: -0.36%
PTGX | $25.61 1.55% 1.52% 450K
|
Health Technology
|
| O: 1.01%
H: 1.64%
C: 1.6%
jnj-2113 pre-clinical positive results
Entera’s Oral Delivery of GLP-2 Pre-Clinical Data to be Published in Peer Reviewed, International Journal of Peptide Research and Therapeutics
Published: 2023-05-03 (Crawled : 13:00) - globenewswire.com
ENTX | $1.985 -11.38% -12.85% 300K
|
Health Technology
|
| O: 6.26%
H: 3.53%
C: 3.52%
pre-clinical international research therapeutics
Orchard Therapeutics Announces New Clinical and Pre-clinical Data at ASGCT 2023
Published: 2023-05-03 (Crawled : 11:00) - globenewswire.com
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: 6.62%
H: 0.0%
C: -5.21%
pre-clinical therapeutics
Pre-Clinical Data of Palatin's Melanocortin Agonist Demonstrating Therapeutic Effects in Diabetic Retinopathy and Uveitis Published in the International Journal of Molecular Sciences
Published: 2023-04-18 (Crawled : 12:00) - biospace.com/
PTN | $1.84 -2.65% 0.05% 150K
|
Health Technology
|
| O: 4.53%
H: 0.0%
C: -4.33%
pre-clinical agonist international sciences molecular diabetic
BriaCell Announces Intention to Spin-Out Certain Pre-Clinical Assets into a Newly Created “SpinCo” Entity whereby Shareholders to Receive One New Share of “SpinCo” in Addition to Each Current Share of BriaCell Already Held
Published: 2023-03-30 (Crawled : 13:00) - globenewswire.com
BCTX | $2.19 -5.6% -5.94% 140K
|
Professional, Scientific, and T...
|
| O: 3.23%
H: 1.22%
C: -2.45%
pre-clinical one
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.